Item 5.02. Departure of Directors or Principal Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
Elaine Castellanos, Senior Vice President-Finance and Chief Accounting Officer
of Reata Pharmaceuticals, Inc. (the "Company"), has informed the Company that
she intends to retire at such time as the Company has identified a successor to
assume her role as Chief Accounting Officer of the Company. The Company
anticipates that her successor will be appointed on or before the end of 2021.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses